IL27 and neoplasm: The pharmacokinetics of Cas9mIL30-mPSCA NxPs in IL30-TRAMP-C1 tumor-bearing C57BL/6J mice were comparable to those of Cas9hIL30-hPSCA NxPs in DU145 tumor- and PC3 tumor-bearing mice (Fig. 8g).